Mohammad I Khan
Overview
Explore the profile of Mohammad I Khan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
585
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matthews C, Omar A, Khan M, Marinelli J, Elias J, Konje S, et al.
Int J Cardiol
. 2024 Oct;
419:132668.
PMID: 39442760
Background: We studied the prognostic value of exercise tolerance and exercise-associated diastolic dysfunction (Ex-DD) in elderly patients referred for exercise stress echocardiography (ExE). Methods: A total of 674 patients ≥60 ...
2.
Batool H, Khan M, Ain Q, Chughtai O, Khan M, Khan M, et al.
Glob Cardiol Sci Pract
. 2024 Oct;
2024(4):e202437.
PMID: 39351483
Background: Lipoprotein(a) [Lp(a)] is a highly atherogenic particle identified as an independent risk factor for the development of atherosclerotic cardiovascular disease (ASCVD). This study aimed to investigate the frequency of...
3.
Khan M, Khare A, Ali I, Nasir A
J Oral Maxillofac Pathol
. 2023 Nov;
27(3):553-556.
PMID: 38033938
Angiofibroma also called juvenile nasopharyngeal angiofibroma are tumors of adolescence and the commonest site is the nasopharynx. Extra nasopharyngeal sites include upper respiratory and digestive tracts, oral cavity, tonsils, larynx,...
4.
Idrees M, U Rahman I, A Khan H, M Yousufzai Y, H Khan E, Khan M, et al.
Pak J Pharm Sci
. 2023 Oct;
36(5):1451-1456.
PMID: 37869921
Endothelial dysfunction (ED) is a significant risk factor of blood vessel related diseases of diabetes and this study evaluate the effect of adding Momordica charantia (Mc) to glibenclamide (GLB) on...
5.
Nasir A, Khare A, Ali I, Khan M
J Oral Maxillofac Pathol
. 2023 Apr;
27(Suppl 1):S60-S63.
PMID: 37082286
Ameloblastic fibroma is a rare mixed odontogenic benign tumor that can occur in either mandible or maxilla but mostly it is found in posterior region of mandible. It can present...
6.
Omar A, Khayat M, Ahmed F, Muhammad Y, Malebari A, Ibrahim S, et al.
Front Oncol
. 2022 Jun;
12:879457.
PMID: 35669422
Tirbanibulin (KX2-391, KX-01), a dual non-ATP (substrate site) Src kinase and tubulin-polymerization inhibitor, demonstrated a universal anti-cancer activity for variety of cancer types. The notion that KX2-391 is a highly...
7.
Khayat M, Omar A, Ahmed F, Khan M, Ibrahim S, Muhammad Y, et al.
Front Pharmacol
. 2022 Jan;
12:794325.
PMID: 35069208
Structural changes of small-molecule drugs may bring interesting biological properties, especially in the field of kinase inhibitors. We sought to study tirbanibulin, a first-in-class dual Src kinase (non-ATP competitive)/tubulin inhibitor...
8.
Nadeem M, Razeeth M, Choudhry H, Anwar F, Zamzami M, Murtaza B, et al.
J Cell Biochem
. 2019 Jun;
121(1):125-134.
PMID: 31232490
Escherichia coli is frequently exploited for genetic manipulations and heterologous gene expression studies. We have evaluated the metabolic profile of E. coli strain BL21 (DE3) RIL CodonPlus after genetic modifications...
9.
Mandal P, Khan M, Shah S
Cont Lens Anterior Eye
. 2018 Aug;
41(6):547.
PMID: 30131216
No abstract available.
10.
Younis T, Khan M, Khan M, Rasul A, Majid M, Adhami V, et al.
Mol Carcinog
. 2018 May;
57(10):1267-1277.
PMID: 29802724
We recently identified and characterized nummularic acid (NA) as a major chemical constituent of Fraxinus xanthoxyloides, a medicinal plant used for over hundred years in traditional medicine. In this study,...